Growth hormone status in morbidly obese subjects and correlation with body composition

Journal of Endocrinological Investigation

Volumn 29, Issue 6, 2006, Pages 536-543

  Savastano, S ^a   Di Somma, C ^a   Belfiore, A ^a   Guida, B ^a   Orio Jr , F ^a   Rota, F ^a   Savanelli, M C ^a   Cascella, T ^a   Mentone, A ^a   Angrisani, L ^b   Lombardi, G ^a   Colao, A ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b S Giovanni Bosco of Naples ^*  (Italy)

Author keywords

Body composition; GH deficiency; IGF I; Obesity

Indexed keywords

ARGININE; GROWTH HORMONE; SERMORELIN; SOMATOMEDIN C;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENDOCRINE DISEASE; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HUMAN; HYPOPHYSIS DISEASE; IMMUNORADIOMETRIC ASSAY; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; PROVOCATION TEST; SCORING SYSTEM; SEX DIFFERENCE; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

EID: 33746706754     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03344144     Document Type: Article

References (35)

1. Kopelman PG. Hormones and obesity. Baillieres Clin Endocrinol Metab 1994, 8: 549-75.
2. Pasquali R, Vicennati V, Gambineri A, Pagotto U. Hormones and pathophysiology of obesity. Eat Weight Disord 2001, 6 (3 Suppl): 9-20.
3. Aronne LJ, Segal KR. Adiposity and fat distribution outcome measures: assessment and clinical implications. Obes Res 2002, 10 (Suppl 1): 14S-21S.
4. Scacchi M, Pincelli AI, Cavagnini F. Growth hormone in obesity. Int J Obesity 1999, 23: 262-71.
5. Giustina A, Veldhuis JD. Pathophysiology of the neuroregulation of growth hormones secretion in experimental animals and the human. Endocr Rev 1998, 19: 717-97.
6. Franco C, Bengtsson BA, Johannsson G. Visceral obesity and the role of the somatotropic axis in the development of metabolic complications. Growth Horm IGF Res 2001, 11 (Suppl A): S97-102.
7. Maccario M, Tassone F, Grottoli S, Rossetto R, Gauna C, Ghigo E. Neuroendocrine and metabolic determinants of the adaptation of GH/IGF-I axis to obesity. Ann Endocrinol (Paris) 2002, 63: 140-4.
8. Qu XD, Gonzalo TGI, Al Sayed MY, et al. Influence of body mass index and gender on GH responses to GHRH plus Arginine and Insulin tolerance test. J Clin Endocrinol Metab 2005, 90: 1563-9.
9. Veldhuis JD, Iranmanesh A, Ho KK, Waters MJ, Johnson ML, Lizarralde G. Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab 1991, 72: 51-9.
10. Colao A, Di Somma C, Pivonello R, et al. Bone loss is correlated to the severity of growth hormone (GH) deficiency in adult patients with hypopituitarism. J Clin Endocrinol Metab 1999, 84: 1919-24.
11. Colao A, Cerbone G, Pivonello R, et al. The growth hormone (GH) response to arginine plus GH releasing hormone test is correlated to the severity of lipid profile abnormalities in adult patients with GH deficiency. J Clin Endocrinol Metab 1999, 84: 1277-82.
12. Colao A, Di Somma C, Cuocolo A, et al. The severity of growth hormone deficiency correlates with the severity of cardiac impairment in 100 adult patients with hypopituitarism: an observational, case-control study. J Clin Endocrinol Metab 2004, 89: 5998-6004.
13. Murray RD, Adams JE, Shalet SM. Adults with partial growth hormone deficiency have an adverse body composition. J Clin Endocrinol Metab 2004, 89: 1586-91.
14. Ghigo E, Aimaretti G, Gianotti L, Bellone J, Arvat E, Camanni F. New approach to the diagnosis of growth hormone deficiency in adults. Eur J Endocrinol 1996, 134: 352-6.
15. Biller BM, Samuels MH, Zagar A, et al. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab 2002, 87: 2067-79.
16. Corneli G, Di Somma C, Baldelli R, et al. The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index. Eur J Endocrinol 2005, 153: 257-64.
17. Hu FB, Rimm E, Smith-Warner SA, et al. Reproducibility and validity of dietary patterns assessed with a food-frequency questionnaire. Am J Clin Nutr 1999, 69: 243-9.
18. Kushner RF. Bioelectrical impedance analysis: A review of principles and applications. J Am Coll Nutr 1992, 11: 199-209.
19. Kotler DP, Burastero S, Wang J, et al. Prediction of body cell mass, fat-free mass, and total body water with bioelectrical impedance analysis: effect of race, sex, and disease. Am J Clin Nutr 1996, 64: 489S-97S.
20. Piccoli A, Rossi B, Pillon L, Bucciante G. A new method for monitoring body fluid variation by bioimpedance analysis: The RXc graph. Kidney Int 1994, 46: 534-9.
21. Piccoli A, Brunani A, Savia G, et al. Discriminating between body fat and fluid changes in the obese adult using bioimpedance vector analysis. Int J Obes 1998, 22: 97-104.
22. Savastano S, Belfiore A, Guida B, et al. A Role of dehydroepiandrosterone-sulphate levels on body composition after laparoscopic adjustable gastric banding in premenopausal morbidly obese women. J Endocrin Invest 2005, 28: 509-15.
23. Growth Hormone Research Society Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. J Clin Endocrinol Metab 1998, 83: 379-81.
24. Fisker S, Jorgensen JO, Christiansen JS. Variability in growth hormone stimulation tests. Growth Horm IGF Res 1998, 8 (Suppl A): 31-5.
25. Aimaretti G, Corneli G, Razzore P, et al. Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone+arginine as provocative tests for the diagnosis of GH deficiency in adults. J Clin Endocrinol Metab 1998, 83: 1615-8.
26. Aimaretti G, Baffoni C, Di Vito L, et al. Comparisons among old and new provocative tests of GH secretion in 178 normal adults. Eur J Endocrinol 2000, 142: 347-52.
27. Imaki T, Shibasaki T, Shizume K, et al. The effect of free fatty acids on growth hormone (GH)-releasing hormone-mediated GH secretion in man. J Clin Endocrinol Metab 1985, 60: 290-3.
28. Casanueva FF, Villanueva L, Dieguez, et al. A free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at he pituitary. J Clin Endocrinol Metab 1987, 65: 634-42.
29. Maccario M, Procopio M, Loche S, et al. Interaction of free fatty acids and arginine on growth hormone secretion in man. Metabolism 1994, 43: 223-6.
30. Iranmanesh A, Lizarralde G, Veldhuis JD. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab 1991, 73: 1081-8.
31. Busetto L, Baggio MB, Zurlo F, Carraro R, Digito M, Enzi G. Assessment of abdominal fat distribution in obese patients: anthropometry versus computerized tomography. Int J Obes Relat Metab Disord 1992, 16: 731-6.
32. Maccario M, Ramunni J, Oleandri SE, et al. Relationships between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients. Int J Obes 1999, 23: 612-8.
33. Santini F, Pinchera A, Marsili A, et al. Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid diseases J Clin Endocrinol Metab 2005, 90: 124-7.
34. Veldhuis JD. Gender differences in secretory activity of the human somatotropic (growth hormone) axis. Eur J Endocrinol 1996, 134: 287-95.
35. van den Berg G, Veldhuis JD, Frolich M, Roelfsema F. An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and premenopausal women. J Clin Endocrinol Metab 1996, 81: 2460-7.